,
Evaluation de la mise en place des recommandations ,
,
,
,
,
, Annexe 1: Classification TNM (7ème édition), 2009.
, Recommandations locales sur la prise en charge de l'anémie, vol.2
, Grille de recueil, vol.3
, , 2017.
The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients, Eur J Cancer, vol.40, issue.15, pp.2293-306, 2004. ,
Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment), Bull Cancer, vol.94, issue.10, pp.907-921, 2007. ,
Chemotherapy-Induced Anemia in Adults: Incidence and Treatment, JNCI J Natl Cancer Inst, vol.91, pp.1616-1650, 1999. ,
Haematological toxicity of cranio-spinal irradiation, Radiother Oncol, vol.48, issue.1, pp.23-30, 1998. ,
DOI : 10.1016/s0167-8140(98)00024-3
Cancer-and Chemotherapy-Induced Anemia, J Natl Compr Canc Netw, vol.10, issue.5, pp.628-53, 2012. ,
DOI : 10.6004/jnccn.2012.0064
URL : http://www.jnccn.org/content/10/5/628.full.pdf
A prospective study of quality of life and treatment of chemotherapy-induced anaemia in lung cancer, Rev Mal Respir, vol.24, issue.1, pp.41-48, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00597137
, Anémie et cancer-AFSOS
, Soins Oncol. Support, 2017.
ASCO/ASH Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer, J Clin Oncol, vol.28, issue.33, pp.4996-5010, 2010. ,
update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents, The Oncologist, vol.13, issue.3, pp.33-39, 2007. ,
DOI : 10.1634/theoncologist.13-s3-33
URL : http://theoncologist.alphamedpress.org/content/13/suppl_3/33.full.pdf
Detection, evaluation, and management of iron-restricted erythropoiesis, Blood, vol.116, issue.23, pp.4754-61, 2010. ,
DOI : 10.1182/blood-2010-05-286260
URL : http://www.bloodjournal.org/content/116/23/4754.full.pdf
Iron deficiency syndromes and iron-restricted erythropoiesis (CME), vol.52, pp.1584-92, 2012. ,
DOI : 10.1111/j.1537-2995.2011.03495.x
Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis, Can Med Assoc J, vol.180, issue.11, pp.62-71, 2009. ,
Erythropoietin or Darbepoetin for patients with cancermeta-analysis based on individual patient data, Cochrane Database Syst Rev, issue.3, p.7303, 2009. ,
DOI : 10.1002/14651858.cd007303.pub2
URL : https://boris.unibe.ch/30199/1/Bohlius%20CochraneDatabaseSystRev%202009.pdf
, , 2011.
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, issue.5, pp.359-86, 2015. ,
DOI : 10.1002/ijc.29210
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.29210
, Les cancers en France en 2014-L'essentiel des faits et chiffres-Ref : ETKFRANCESYN15 | Institut National Du Cancer, 2017.
Amélioration de la survie à 1 an dans le cancer du poumon en France. Résultats des études prospectives en vie réelle, Rev Pneumol Clin, vol.72, issue.3, pp.163-70, 2016. ,
DOI : 10.1016/j.pneumo.2016.02.002
, Quelques chiffres-Cancer du poumon | Institut National Du Cancer, 2017.
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey, J Thorac Oncol, vol.5, issue.1, pp.29-33, 2010. ,
Le cancer bronchopulmonaire en France: quels changements en 10 ans ?, Lett Pneumol, vol.16, issue.5, pp.189-93, 2013. ,
KBP-2010-CPHG: Characteristics and management of 6,083 new cases of non-small-cell-lung-cancer (NSCLC), Eur Respir J, vol.40, p.3128, 2012. ,
Impact of limiting erythropoiesis-stimulating agent use for chemotherapy-induced anemia on the United States blood supply margin, Transfusion (Paris), vol.49, issue.5, pp.895-902, 2009. ,
Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study, Eur J Cancer Oxf Engl, vol.45, issue.9, pp.1603-1618, 1990. ,
Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study, Future Oncol Lond Engl, vol.11, issue.11, pp.1665-74, 2015. ,
Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia-systematic review and meta-analysis of randomised controlled trials, Acta Oncol, vol.52, issue.1, pp.18-29, 2012. ,
Impact of a Patient Blood Management Program and an Outpatient Anemia Management Protocol on Red Cell Transfusions in Oncology Inpatients and Outpatients, The Oncologist, vol.21, issue.3, pp.327-359, 2016. ,
Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study, Curr Med Res Opin, vol.28, issue.7, pp.1089-99, 2012. ,
Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation, ANNEXES Annexe, vol.97, issue.1, pp.116-138, 2009. ,